Transport of Small Aliphatic Amines by Polyspecific Solute Carriers: Deciphering Structure–Function Relationships

IF 3.7 Q1 CHEMISTRY, MEDICINAL
Wouroud Ismail Al-Khalil, Jürgen Brockmöller and Muhammad Rafehi*, 
{"title":"Transport of Small Aliphatic Amines by Polyspecific Solute Carriers: Deciphering Structure–Function Relationships","authors":"Wouroud Ismail Al-Khalil,&nbsp;Jürgen Brockmöller and Muhammad Rafehi*,&nbsp;","doi":"10.1021/acsptsci.5c00340","DOIUrl":null,"url":null,"abstract":"<p >Membrane proteins of the solute carrier (SLC) 22A and 47A families are polyspecific transporters critical for handling diverse endogenous and exogenous compounds, including many clinically relevant drugs. However, their substrate specificity remains poorly understood. To address this, we conducted a structure–function relationship analysis focusing on small aliphatic amines (alkylamines and alkanolamines) and enantioselectivity of their transport. Using HEK293 cells stably overexpressing organic cation transporters (OCT) 1, 2, or 3 (<i>SLC22A1</i>, <i>-2</i>, or <i>-3</i>) or multidrug and toxin extrusion transporters (MATE) 1 or 2-K (<i>SLC47A1</i> and <i>-2</i>), substrate transport was quantified through liquid chromatography─tandem mass spectrometry, with 6-aminoquinolyl-<i>N</i>-hydroxysuccinimidyl carbamate derivatization as needed. While most tested compounds exhibited physicochemical properties consistent with typical OCT and MATE substrates, compounds with a molecular weight of less than 145 Da were mostly not transported by OCT1, OCT3, or the MATEs. However, in great contrast, OCT2 demonstrated robust transport of small aliphatic amines and alkanolamines (molecular weight of 60–145 Da), with modest stereoselectivity favoring (<i>S</i>)-enantiomers. Structural complexity, such as carbon chain length and amino group positioning, strongly influenced transport activity and kinetics, while compounds with more than two positive charges at different positions were not transported. Additionally, we identified a novel role for OCT2 as an efficient efflux transporter for ethanolamine. These findings reveal critical molecular determinants underlying SLC-mediated transport, enhancing our understanding of OCT and MATE substrate preferences and mechanisms. This knowledge provides a foundation for better predicting transporter interactions and optimizing drug design.</p>","PeriodicalId":36426,"journal":{"name":"ACS Pharmacology and Translational Science","volume":"8 8","pages":"2777–2794"},"PeriodicalIF":3.7000,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/pdf/10.1021/acsptsci.5c00340","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Pharmacology and Translational Science","FirstCategoryId":"1085","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsptsci.5c00340","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Membrane proteins of the solute carrier (SLC) 22A and 47A families are polyspecific transporters critical for handling diverse endogenous and exogenous compounds, including many clinically relevant drugs. However, their substrate specificity remains poorly understood. To address this, we conducted a structure–function relationship analysis focusing on small aliphatic amines (alkylamines and alkanolamines) and enantioselectivity of their transport. Using HEK293 cells stably overexpressing organic cation transporters (OCT) 1, 2, or 3 (SLC22A1, -2, or -3) or multidrug and toxin extrusion transporters (MATE) 1 or 2-K (SLC47A1 and -2), substrate transport was quantified through liquid chromatography─tandem mass spectrometry, with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate derivatization as needed. While most tested compounds exhibited physicochemical properties consistent with typical OCT and MATE substrates, compounds with a molecular weight of less than 145 Da were mostly not transported by OCT1, OCT3, or the MATEs. However, in great contrast, OCT2 demonstrated robust transport of small aliphatic amines and alkanolamines (molecular weight of 60–145 Da), with modest stereoselectivity favoring (S)-enantiomers. Structural complexity, such as carbon chain length and amino group positioning, strongly influenced transport activity and kinetics, while compounds with more than two positive charges at different positions were not transported. Additionally, we identified a novel role for OCT2 as an efficient efflux transporter for ethanolamine. These findings reveal critical molecular determinants underlying SLC-mediated transport, enhancing our understanding of OCT and MATE substrate preferences and mechanisms. This knowledge provides a foundation for better predicting transporter interactions and optimizing drug design.

多特异性溶质载体运输小脂肪胺:解析结构-功能关系
溶质载体(SLC) 22A和47A家族的膜蛋白是处理各种内源性和外源性化合物(包括许多临床相关药物)的多特异性转运蛋白。然而,它们的底物特异性仍然知之甚少。为了解决这个问题,我们对小脂肪胺(烷基胺和烷醇胺)及其转运的对映选择性进行了结构-功能关系分析。利用HEK293细胞稳定过表达有机阳离子转运体(OCT) 1、2或3 (SLC22A1、-2或-3)或多药物和毒素挤压转运体(MATE) 1或2- k (SLC47A1和-2),通过液相色谱─串联质谱法定量底物转运,根据需要进行6-氨基喹啉- n -羟基琥珀酰氨基甲酸酯衍生化。虽然大多数被测化合物的物理化学性质与典型的OCT和MATE底物一致,但分子量小于145 Da的化合物大多不被OCT1、OCT3或MATE转运。然而,相比之下,OCT2表现出小脂肪胺和烷醇胺(分子量为60-145 Da)的强大转运,具有适度的立体选择性,有利于(S)-对映体。结构复杂性,如碳链长度和氨基位置,强烈影响转运活性和动力学,而在不同位置具有两个以上正电荷的化合物不被转运。此外,我们确定了OCT2作为乙醇胺的有效外排转运体的新作用。这些发现揭示了slc介导转运的关键分子决定因素,增强了我们对OCT和MATE底物偏好和机制的理解。这些知识为更好地预测转运体相互作用和优化药物设计提供了基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Pharmacology and Translational Science
ACS Pharmacology and Translational Science Medicine-Pharmacology (medical)
CiteScore
10.00
自引率
3.30%
发文量
133
期刊介绍: ACS Pharmacology & Translational Science publishes high quality, innovative, and impactful research across the broad spectrum of biological sciences, covering basic and molecular sciences through to translational preclinical studies. Clinical studies that address novel mechanisms of action, and methodological papers that provide innovation, and advance translation, will also be considered. We give priority to studies that fully integrate basic pharmacological and/or biochemical findings into physiological processes that have translational potential in a broad range of biomedical disciplines. Therefore, studies that employ a complementary blend of in vitro and in vivo systems are of particular interest to the journal. Nonetheless, all innovative and impactful research that has an articulated translational relevance will be considered. ACS Pharmacology & Translational Science does not publish research on biological extracts that have unknown concentration or unknown chemical composition. Authors are encouraged to use the pre-submission inquiry mechanism to ensure relevance and appropriateness of research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信